DAX24.271 -0,6%Est505.930 -0,9%MSCI World4.343 -0,1%Top 10 Crypto9,6600 +0,1%Nas24.327 -0,3%Bitcoin64.345 -0,1%Euro1,1743 -0,4%Öl97,98 +4,5%Gold4.709 -2,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 SAP 716460 Allianz 840400 Lufthansa 823212 Amazon 906866 Deutsche Telekom 555750 Siemens Energy ENER6Y NEL ASA A0B733 Microsoft 870747 Infineon 623100 Mercedes-Benz Group (ex Daimler) 710000 Plug Power A1JA81 Apple 865985 DroneShield A2DMAA
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX fällt letztlich zurück -- Apple-CEO gibt das Ruder ab -- D-Wave & Co., Allianz, AIXTRON, Novo Nordisk, Blackberry, NVIDIA, Amazon, Siemens Energy, Tesla, DroneShield, Rüstung im Fokus
Top News
EVOTEC-Aktie deutlich höher: Dynamik im Aktionärskreis durch Goldman Sachs EVOTEC-Aktie deutlich höher: Dynamik im Aktionärskreis durch Goldman Sachs
Stellar: So viel Verlust wäre bei einem Investment von vor 5 Jahren angefallen Stellar: So viel Verlust wäre bei einem Investment von vor 5 Jahren angefallen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Aldeyra Therapeutics Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
1,47 EUR -0,04 EUR -2,65 %
FSE
1,73 USD -0,06 USD -3,08 %
BTT
finanzen.net zero
Aldeyra Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.92,00 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA111X8

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS01438T1060

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolALDX

Aldeyra Therapeutics Aktien News

DatumMeistgelesen
BenzingaWhat's Going On With Aldeyra Therapeutics Stock On Thursday?
ZacksIs Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?
ZacksDoes Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect?
Wer­bungAldeyra Therapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
ZacksWall Street Analysts Predict a 65.75% Upside in Aldeyra Therapeutics (ALDX): Here's What You Should Know
ZacksAre Medical Stocks Lagging Aldeyra Therapeutics (ALDX) This Year?
ZacksZacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics
ZacksAldeyra Therapeutics (ALDX) Upgraded to Strong Buy: What Does It Mean for the Stock?
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action against Aldeyra Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ALDX
PR NewswireFinal Deadline Alert: ALDX Investor Alert: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Aldeyra Therapeutics, Inc. Class Action Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action against Aldeyra Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ALDX
PR NewswireSHAREHOLDER ALERT: Levi & Korsinsky Notifies Aldeyra Therapeutics, Inc.(ALDX) Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action against Aldeyra Therapeutics, Inc. and Certain Officers - ALDX
PR NewswireSHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Aldeyra Investors of a Lead Plaintiff Deadline of September 29, 2023
PR NewswireALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action against Aldeyra Therapeutics, Inc. and Certain Officers - ALDX
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aldeyra Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 29, 2023 - (NASDAQ: ALDX)
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action against Aldeyra Therapeutics, Inc. and Certain Officers - ALDX
PR NewswireSHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 29, 2023 in the Class Action Filed on Behalf of Aldeyra Therapeutics, Inc.(ALDX) Shareholders
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action Against Aldeyra Therapeutics, Inc. and Certain Officers - ALDX
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aldeyra Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 29, 2023 - (NASDAQ: ALDX)
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action Against Aldeyra Therapeutics, Inc. and Certain Officers - ALDX
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action Against Aldeyra Therapeutics, Inc. and Certain Officers - ALDX
PR NewswireALDX INVESTOR NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action...
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX

Aldeyra Therapeutics News

Aldeyra Therapeutics News: auf dieser Seite finden Sie alle Aldeyra Therapeutics News und Nachrichten zur Aldeyra Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Aldeyra Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Aldeyra Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.